Compumedics Ltd (ASX: CMP) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Compumedics Ltd Chart and Price Data
Fundamentals Data provided by Morningstar.
Data provided by Morningstar.Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Compumedics Ltd (ASX: CMP)
Latest News
⏸️ Investing
Why these 4 ASX shares started the week in the red
⏸️ Investing
Why the Compumedics Limited share price fell 19% today
⏸️ Investing
Why these 4 ASX shares are ending the week deep in the red
⏸️ Investing
Why these 4 ASX shares have jumped higher today
⏸️ Investing
Why the Compumedics Limited share price rocketed 43% higher
⏸️ Investing
3 ASX shares at 52-week lows: Are they in the bargain bin?
⏸️ Investing
Top stock picks for February
⏸️ Investing
4 small-cap healthcare shares that you need to know about
⏸️ Investing
3 small-cap shares on my radar for 2017
⏸️ Investing
4 shares under $1 with huge potential
⏸️ Investing
5 small caps that could be the blue-chips of tomorrow
CMP ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
---|---|---|---|---|---|
YesNo |
About Compumedics Ltd
Compumedics Ltd is a medical device company. It is engaged in the development, manufacture, and commercialisation of diagnostic technologies for sleep, brain and ultrasonic blood-flow monitoring applications. The company is organized into geographical operating segments, being the United States of Americas, Australia and the Asia Pacific, and Europe and the Middle East. It derives a majority of its revenue from Australia and the Asia Pacific region.
CMP Share Price History Data provided by Morningstar.
Date | Close | Change | % Change | Volume | Open | High | Low |
---|---|---|---|---|---|---|---|
26 Mar 2024 | $0.29 | $0.00 | 0.00% | 27,633 | $0.28 | $0.29 | $0.28 |
25 Mar 2024 | $0.28 | $0.00 | 0.00% | 12,596 | $0.28 | $0.28 | $0.28 |
22 Mar 2024 | $0.28 | $0.01 | 3.70% | 31,124 | $0.28 | $0.28 | $0.28 |
20 Mar 2024 | $0.27 | $0.00 | 0.00% | 29 | $0.27 | $0.27 | $0.27 |
19 Mar 2024 | $0.27 | $-0.02 | -6.96% | 44,211 | $0.29 | $0.29 | $0.27 |
18 Mar 2024 | $0.29 | $0.00 | 0.00% | 13,020 | $0.29 | $0.29 | $0.29 |
14 Mar 2024 | $0.29 | $0.00 | 0.00% | 6,604 | $0.29 | $0.29 | $0.29 |
12 Mar 2024 | $0.28 | $0.01 | 3.64% | 5,000 | $0.28 | $0.28 | $0.28 |
11 Mar 2024 | $0.28 | $0.01 | 3.70% | 34,836 | $0.27 | $0.28 | $0.27 |
08 Mar 2024 | $0.27 | $0.00 | 0.00% | 30,420 | $0.27 | $0.27 | $0.27 |
07 Mar 2024 | $0.27 | $-0.01 | -3.64% | 27,058 | $0.27 | $0.27 | $0.27 |
06 Mar 2024 | $0.28 | $-0.02 | -6.78% | 142,823 | $0.30 | $0.30 | $0.27 |
05 Mar 2024 | $0.30 | $-0.04 | -12.12% | 57,979 | $0.32 | $0.32 | $0.30 |
04 Mar 2024 | $0.33 | $-0.02 | -5.71% | 95,703 | $0.35 | $0.35 | $0.32 |
Directors & Management Data provided by Morningstar.
Name | Title | Start Date | Profile |
---|---|---|---|
Dr David Burton | Chief Executive OfficerExecutive ChairmanExecutive Director | Nov 1987 |
Mr Burton is Founder and major shareholder through related entity. Dr. Burton's engineering background includes the design and project management of the Compumedics' first sleep laboratory and portable sleep systems. Dr. Burton has authored fifteen patents or patent applications that form part of Compumedics' key intellectual property. Experience in the development, design, manufacture and sale of medical devices and the development of the business.
|
Mr David Lawson | Chief Financial OfficerCompany SecretaryExecutive Director | Oct 2013 |
Mr Lawson Has experience in the development of the Compumedics business over the last 22 years and prior to that held a number of management positions with another listed public entity.
|
Mr Rod James North | Non-Executive Director | Oct 2022 |
Mr North has been working in the financial services & corporate sector for 30 years, having held leading roles in share broking, investment and funds management and provided investor relations, media & PR services to a range of ASX listed companies over the past 17 years. He has experience in company analysis and financial management. He has served on several investment committees in funds management. He has also acted in corporate advisory roles to private and public companies at senior executive and board level, advising on capital raisings, communication, and investor relations strategies.
|
Warwick Freeman | Chief Technology Officer |
-
|
|
Dieter Grossegger | Compumedics alpha trace |
-
|
|
Christoph Witte | General Managing Director |
-
|
Top Shareholders Data provided by Morningstar.
Name | Shares | Capital |
---|---|---|
D & DJ Burton Holding Pty Ltd | 96,002,819 | 54.19% |
B & R James Investment Pty Ltd | 7,200,000 | 4.06% |
HSBC Custody Nominees(Australia) Ltd | 6,917,044 | 3.90% |
Beijing Bestmed Tech Ltd | 4,901,961 | 2.77% |
Medigas Italias S R L | 4,333,333 | 2.45% |
Mr David Francis Lawson & Ms Michelle Gabrielle Callinan | 2,464,482 | 1.39% |
Electro Molecular Pty Ltd | 2,041,500 | 1.15% |
Valui Pty Ltd | 1,830,987 | 1.03% |
Ms Karin Jones | 1,209,576 | 0.68% |
Knowler Property Pty Ltd | 1,198,000 | 0.68% |
Mr Bernard Frederick Knowler & Mrs Robynne lynette Knowler | 1,120,000 | 0.63% |
Mr Mark David Holder | 1,030,000 | 0.58% |
Mr Nigel Strong | 1,008,786 | 0.57% |
Mr David Francis Lawson | 1,006,242 | 0.57% |
J P Morgan Nominees Australia Pty Ltd | 1,000,000 | 0.56% |
Zigsuper Pty Ltd | 900,000 | 0.51% |
BFA Super Pty Ltd | 832,286 | 0.47% |
Avianto Pty Ltd | 784,534 | 0.44% |
Canucki Pty Ltd | 749,469 | 0.42% |
Mr Bruce Dennis Lusty & Mrs Jan Denise Lusty | 737,883 | 0.42% |